R. Bergmann

Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers

M. Bachmann, D. Máthé, K. Szigeti, 2020, Journal of Experimental & Clinical Cancer Research.

“UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells

D. Jäger, B. Seliger, W. Wels, 2020, Scientific Reports.

An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells

R. Bergmann, M. Bachmann, A. Feldmann, 2019, Scientific Reports.

Nanosensors in clinical development of CAR-T cell immunotherapy.

G. Cuniberti, M. Bachmann, L. Baraban, 2022, Biosensors & bioelectronics.

Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T Cells

D. Lindner, A. Feldmann, M. Bachmann, 2022, International journal of molecular sciences.

FLT3-directed UniCAR T-cell therapy of acute myeloid leukaemia.

M. Bachmann, M. Wobus, M. Bornhäuser, 2023, British journal of haematology.

Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5

Jens Pietzsch, Christin Neuber, H. Pietzsch, 2023, International journal of molecular sciences.

A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells

B. Seliger, Z. Kis, J. Drexler, 2023, Frontiers in Immunology.